Finance

Beta
Lists
CEVI:STO
CellaVision AB
SEK 121.00
+0.33%
(+0.40) 1D
Jun 3, 3:57:35 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CEVI...
Open
SEK 120.20
High
SEK 122.80
Low
SEK 120.20
Mkt. cap
2.88B
Avg. vol.
59.12K
Volume
12.53K
52-wk high
SEK 202.50
52-wk low
SEK 117.60
Shares outstanding
23.85M
No. of employees
241
Open
SEK 120.20
High
SEK 122.80
Low
SEK 120.20
Mkt. cap
2.88B
Avg. vol.
59.12K
Volume
12.53K
52-wk high
SEK 202.50
52-wk low
SEK 117.60
Shares outstanding
23.85M
No. of employees
241
News stories
From sources across the web
About CellaVision AB
CEOSimon Østergaard
Employees241
Founded1994
Headquarters-
SectorMedical device
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
191.33M
175.63M
197.20M
166.43M
Cost of goods sold
61.76M
54.33M
65.41M
52.43M
Cost of revenue
61.76M
54.33M
65.41M
52.43M
Research and development expenses
22.36M
28.68M
21.95M
29.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.90M
53.07M
54.75M
55.82M
Operating expense
79.26M
81.76M
76.69M
85.49M
Total operating expenses
141.02M
136.09M
142.10M
137.93M
Operating income
50.31M
39.54M
55.10M
28.50M
Other non operating income
-
-
-
-
EBT including unusual items
48.00M
39.23M
54.54M
28.49M
EBT excluding unusual items
48.00M
39.23M
54.54M
28.49M
Income tax expense
10.38M
7.89M
11.93M
5.98M
Effective tax rate
21.64%
20.11%
21.87%
21.00%
Other operating expenses
-
-
-
-
Net income
37.61M
31.34M
42.61M
22.50M
Net profit margin
19.66%
17.84%
21.61%
13.52%
Earnings per share
1.58
1.31
1.79
0.94
Interest and investment income
1.82M
78.00K
8.88M
446.00K
Interest expense
-4.14M
-395.00K
-1.44M
-459.00K
Net interest expenses
-2.32M
-317.00K
7.43M
-13.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
57.65M
47.82M
71.46M
36.92M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more